MOH — authorised 9 December 1983
- Marketing authorisation holder: SANOFI AVENTIS US
- Status: likely_approved
🇮🇱 Gaviscon in Israel
MOH authorised Gaviscon on 9 December 1983
Marketing authorisation
Gaviscon in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Cardiovascular approved in Israel
Frequently asked questions
Is Gaviscon approved in Israel?
Yes. MOH authorised it on 9 December 1983.
Who is the marketing authorisation holder for Gaviscon in Israel?
SANOFI AVENTIS US holds the Israeli marketing authorisation.